Holen Sie sich die Stockscreener-App
0.45
5.42%
-0.0258
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TLRY?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.4758
Offen:
$0.4683
24-Stunden-Volumen:
44.00M
Relative Volume:
1.16
Marktkapitalisierung:
$485.28M
Einnahmen:
$829.22M
Nettoeinkommen (Verlust:
$-248.96M
KGV:
-1.50
EPS:
-0.3
Netto-Cashflow:
$-92.10M
1W Leistung:
-10.96%
1M Leistung:
-30.18%
6M Leistung:
-71.34%
1J Leistung:
-73.84%
1-Tages-Spanne:
$0.43
$0.4838
1-Wochen-Bereich:
$0.43
$0.52
52-Wochen-Spanne:
$0.43
$2.515
Tilray Brands Inc Stock (TLRY) Company Profile
Firmenname
Tilray Brands Inc
Sektor
Telefon
519.322.8800
Adresse
655 MADISON AVENUE, NEW YORK
Vergleichen Sie TLRY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
0.45 | 485.28M | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
148.67 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.22 | 45.62B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.71 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.65 | 15.60B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.73 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-05 | Bestätigt | Alliance Global Partners | Neutral |
| 2022-11-02 | Eingeleitet | Bernstein | Mkt Perform |
| 2022-07-29 | Herabstufung | The Benchmark Company | Hold → Sell |
| 2022-03-04 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-11-18 | Eingeleitet | Barclays | Underweight |
| 2021-11-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-06-11 | Herabstufung | CIBC | Sector Outperform → Neutral |
| 2021-06-03 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-05-11 | Fortgesetzt | Cowen | Outperform |
| 2021-05-07 | Fortgesetzt | Jefferies | Buy |
| 2021-05-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-04-28 | Fortgesetzt | BofA Securities | Buy |
| 2021-02-18 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-02-18 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-11-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-11-11 | Herabstufung | Stifel | Hold → Sell |
| 2020-10-01 | Bestätigt | MKM Partners | Neutral |
| 2020-09-21 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-05-12 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-04-09 | Herabstufung | Consumer Edge Research | Overweight → Equal Weight |
| 2020-02-24 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-01-13 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-11-13 | Bestätigt | The Benchmark Company | Buy |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2019-10-22 | Bestätigt | Piper Jaffray | Overweight |
| 2019-09-20 | Eingeleitet | MKM Partners | Neutral |
| 2019-08-14 | Bestätigt | The Benchmark Company | Buy |
| 2019-07-17 | Eingeleitet | Ladenburg Thalmann | Neutral |
| 2019-06-28 | Eingeleitet | Consumer Edge Research | Overweight |
| 2019-06-06 | Eingeleitet | Stifel | Hold |
| 2019-06-05 | Eingeleitet | Oppenheimer | Perform |
| 2019-05-15 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2019-05-13 | Eingeleitet | Alliance Global Partners | Neutral |
Alle ansehen
Tilray Brands Inc Aktie (TLRY) Neueste Nachrichten
Tilray Brands proposes reverse stock split - MSN
This Week In Cannabis: Carmelo's NY Launch, Federal Reform, Cancer Study, Avicanna's Growth, Tilray's Split, DeSantis Fallout, Slovenia's Big Move And More - Benzinga
Cannabis company Tilray Brands proposes a reverse stock split - Bowen Island Undercurrent
Tilray Beverages Launches Cruisies, a New Line of Ready-To-Drink Cocktails - GlobeNewswire
Struggling Cannabis Firm Tilray Brands (TLRY) Plans Reverse Stock Split - markets.businessinsider.com
Tilray Medical Introduces Cannabis Edibles in Australia - mg Magazine
Tilray (NASDAQ:TLRY) Stock Price Down 1%Should You Sell? - MarketBeat
Tilray Brands (NasdaqGS:TLRY) Schedules Special Meeting to Consider Reverse Stock Split - Yahoo Finance
Why Cannabis Co. Tilray (TLRY) Is Trading Down Today - Benzinga
Vegan, Sugar-Free, And Now In Australia: Tilray's Edibles Aren't Your Average Medical Launch - Benzinga
Tilray stock plunges to 52-week low at $0.44 By Investing.com - Investing.com India
Tilray Proposes Reverse Stock Split To Maintain Nasdaq Compliance And Cut Costs - Nasdaq
Tilray’s stock has been below $1 for months. Here’s how it plans to fix that. - MSN
Tilray Brands announces proposed reverse stock split and corresponding special meeting of stockholders - StratCann
Tilray Brands Announces Proposed Reverse Stock Split - Cannabis Business Times
Tilray (TLRY) Launches New Cruisies Cocktails for Summer in Northeast | TLRY Stock News - GuruFocus
Tilray (TLRY) Launches First Medical Cannabis Edibles in Australia | TLRY Stock News - GuruFocus
Form PRE 14A Tilray Brands, Inc. For: Jun 10 - StreetInsider
Tilray proposes reverse split to drive share price higher - Green Market Report
Tilray Makes Bold Move into Premium RTD Cocktails with New Cruisies LineSee First Products - Stock Titan
Tilray Brands Subsidiary Introduces Cannabis Edibles in Australia; Tilray Seeks Approval for Reverse Stock Split - marketscreener.com
Tilray Medical Breaks Ground: Introduces First-Ever Cannabis Edibles for Australian PatientsSee Product Line - Stock Titan
Tilray (TLRY) Proposes Reverse Stock Split Amid Strategic Adjustments - GuruFocus
Tilray plans reverse stock split to retain Nasdaq listing - Investing.com Australia
Tilray to Seek Approval for Reverse Stock Split at Stockholders' Meeting - MarketScreener
Tilray plans reverse stock split to retain Nasdaq listing By Investing.com - Investing.com India
Tilray (TLRY) Proposes Reverse Stock Split to Enhance Market Position | TLRY Stock News - GuruFocus
Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders | TLRY Stock News - GuruFocus
Tilray Brands falls on reverse stock split plan - TradingView
Tilray Brands proposes reverse stock split (TLRY:NASDAQ) - Seeking Alpha
Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders - GlobeNewswire
Tilray's Strategic Reverse Split Comes With $76M Debt Reduction and Strong $248M Cash Position - Stock Titan
(TLRY) Investment Strategy and Analysis (TLRY:CA) - news.stocktradersdaily.com
Tilray Brands (TLRY) Shows Strong Cannabis Segment Growth - GuruFocus
Alliance Global Partners Predicts Weaker Earnings for Tilray - MarketBeat
Tilray Brands Ranks #4 on the Brewers Association List of Top Producing Craft Brewers in the United States - GlobeNewswire
Tilray (NASDAQ:TLRY) Trading Down 3%Time to Sell? - MarketBeat
Tilray FY2025 EPS Decreased by Alliance Global Partners - MarketBeat
Is Tilray Brands Inc. (NASDAQ:TLRY) the Best Penny Stock to Invest in Under $1? - Insider Monkey
Cannabis Company Tilray Brands Proposes A Reverse Stock Split - Barchart.com
3 Crashing Stocks I Wouldn't Buy Right Now - The Globe and Mail
Tilray Brands Ranks #4 on the Brewers Association List of Top Producing Craft Brewers in the United States | TLRY Stock News - GuruFocus
Tilray Beverages Achieves #4 Ranking in Brewers Association's Top 50 Craft Brewing Companies in the U.S. - Nasdaq
Tilray Surges to #4 in US Craft Beer Rankings: Cannabis Giant's Beverage Empire Grows - Stock Titan
Finanzdaten der Tilray Brands Inc-Aktie (TLRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tilray Brands Inc-Aktie (TLRY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Persofsky Renah | Director |
Nov 08 '24 |
Option Exercise |
1.50 |
11,958 |
17,937 |
75,348 |
| SIMON IRWIN D | President and CEO |
Jul 31 '24 |
Option Exercise |
2.03 |
706,214 |
1,433,614 |
3,637,021 |
| Merton Carl A | Chief Financial Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
703,412 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
468,218 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
583,643 |
| SIMON IRWIN D | President and CEO |
Jul 26 '24 |
Option Exercise |
1.83 |
98,194 |
179,695 |
2,985,109 |
| Merton Carl A | Chief Financial Officer |
Jul 26 '24 |
Option Exercise |
1.83 |
12,166 |
22,264 |
615,102 |
| Looney Thomas P. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
230,038 |
| Hopkinson David G. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
211,185 |
| Herhalt Johann Michael | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
180,514 |
0.74%
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):